Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Resources

Injectable Buprenorphine Resources

Boston Medical Center Injectable Buprenorphine Protocols
Please reference the 2021 Boston Medical Center OBAT Clinical Guidelines, pages 42-50. These guidelines should be used to inform the administration of injectable buprenorphine at Boston Medical Center.
Visit webpage

Consent for Treatment with Injectable Buprenorphine

English
Haitian Creole
Portuguese
Spanish

Extended-Release Buprenorphine: An Instructional Guide

Initiation of Monthly Injectable Buprenorphine
Guidance for starting a patient on monthly injectable buprenorphine, including required preparation and injection day planning. This is not meant to replace clinical decision-making.
Visit webpage

Injectable Buprenorphine Administration Checklist
Checklist for injectable buprenorphine administration. Please reference the 2021 "Addiction Nursing Competencies: A Comprehensive Toolkit for the Addictions Nurse" document, pages 62-63.
Visit webpage

Patient Medication Guide for Injectable Buprenorphine
Visit webpage

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

© 2023 Boston Medical Center. All rights reserved. Site by Root802.